US wants stronger warnings on OTC NSAIDs

9 July 2015 - Deborah Wilkes

Archived

The US Food and Drug Administration (FDA) plans to strengthen the cardiovascular warnings on non-steroidal anti-inflammatory drugs (NSAIDs), including OTC products. The revised warnings will not apply to aspirin.

Click tags below for more information on topics:

FDA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: